This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Prospect Hill Management | |
|---|---|
| Name | Prospect Hill Management |
| Type | Private investment firm |
| Founded | 1993 |
| Founders | Robert D. Foisie |
| Headquarters | Boston, Massachusetts |
| Industry | Hedge fund, Private equity |
| Products | Long/short equity, Event-driven, Activist investing |
| Assets under management | US$6 billion (2020 est.) |
| Employees | 50–100 (2019) |
Prospect Hill Management
Prospect Hill Management is an American investment firm founded in 1993 and headquartered in Boston, Massachusetts. The firm is known for activist and event-driven strategies, investments in small- and mid-cap public companies, and involvement in corporate governance campaigns. Prospect Hill has engaged with numerous public companies and institutional investors on strategic and operational change.
Prospect Hill Management was established in 1993 by Robert D. Foisie following his tenure in Boston-area investment circles and connections to Harvard University alumni networks. Early in its existence the firm operated alongside Boston-area contemporaries such as Tudor Investment Corporation and Wellington Management Company while participating in the 1990s expansion of activist investing popularized by firms like Calisma Capital Management and Elliott Management Corporation. In the 2000s Prospect Hill expanded its footprint by pursuing stakes in industrial, technology, and biotechnology companies, interacting with capital markets events including initial public offerings and merger-and-acquisition activity influenced by institutions like BlackRock, State Street Corporation, and Vanguard Group. The firm’s campaigns have intersected with proxy contests, board reorganizations, and sale processes involving participants such as Goldman Sachs, Morgan Stanley, and regional investment banks.
Prospect Hill operates as a privately owned hedge fund and investment adviser offering long/short equity and activist-oriented strategies to accredited investors and institutional clients, including pension funds and endowments. Its services have included concentrated equity positions, negotiated restructurings, and collaborative engagements with corporate boards and management teams, similar in approach to strategies used by Pershing Square Capital Management and Third Point LLC. The firm provides portfolio construction, risk management, and shareholder engagement, interfacing with custodians and prime brokers such as J.P. Morgan and Citigroup. Prospect Hill’s model relies on identifying undervalued securities and pursuing changes through board representation, strategic alternatives, or public campaigning, often coordinating with proxy advisory firms like Institutional Shareholder Services and Glass Lewis.
Prospect Hill has historically focused on small- and mid-cap public companies across sectors including technology, healthcare, industrials, and consumer goods. The firm employs fundamental research, activist catalysts, and event-driven theses akin to those utilized by Carl Icahn-style investors and event investors such as Elliott Management Corporation. Its portfolio has included stakes in biotechnology firms that interacted with regulatory pathways involving the Food and Drug Administration and in manufacturing companies subject to supply-chain shifts linked to global trade developments with partners like China and Mexico. Prospect Hill often seeks board seats, share buybacks, divestitures, or sales to strategic buyers including Berkshire Hathaway-type acquirers or private equity firms such as The Carlyle Group and KKR. The firm’s holdings have been monitored by sell-side analysts at firms like Morgan Stanley and Goldman Sachs and covered by financial press including The Wall Street Journal and Bloomberg News.
Prospect Hill’s organizational structure is typical of mid-sized activist hedge funds: a small senior investment team, portfolio managers, research analysts, and operations staff handling compliance and investor relations. Senior leadership has included founder Robert D. Foisie and a cadre of portfolio managers with prior experience at firms such as Putnam Investments and Fidelity Investments. The firm’s governance includes a managing partner model, and it engages outside counsel and auditors from major firms like Skadden, Arps, Slate, Meagher & Flom and Deloitte. Prospect Hill has maintained offices in the Boston financial cluster, interacting with legal and accounting professionals from institutions such as Ropes & Gray and PwC.
Prospect Hill’s performance record has produced periods of outperformance driven by successful activist campaigns as well as drawdowns tied to concentrated bets and market dislocations like the 2008 financial crisis and the 2020 market volatility surrounding the COVID-19 pandemic. The firm has been credited for unlocking shareholder value in select situations but also faced criticism common to activist investors regarding short-termism and fee structures, in debates mirrored by critics and proponents including commentators at The Financial Times and The New York Times. Prospect Hill has been involved in high-profile proxy fights and contested restructurings that drew attention from corporate target management teams, competing activists such as ValueAct Capital and Icahn Enterprises, and large institutional investors including CalPERS.
As an SEC-registered investment adviser engaged in activist investing, Prospect Hill has been subject to regulation by the U.S. Securities and Exchange Commission and disclosure requirements under the Securities Exchange Act of 1934. The firm’s campaigns have occasionally led to regulatory scrutiny and litigation, including shareholder derivative suits, proxy disputes under rules administered by the SEC Office of the Chief Accountant, and compliance reviews related to trading and disclosure overseen by the Financial Industry Regulatory Authority. Prospect Hill has also navigated regulatory frameworks affecting mergers and acquisitions, including antitrust review by the Department of Justice and filings with the Federal Trade Commission in transactions that implicated competition policy.
Category:Hedge funds in the United States